Passage Bio Investors

54 investors on Angel Roster list Passage Bio in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, China and Israel.

Investors are matched on the company name in their portfolio, so companies that share the name Passage Bio can appear together.

Investors listed
54
With verified email
33%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 Passage Bio investors

The most complete profiles first. Showing 40 of 54.

  • Albert ChaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more

    Verified email available

  • Brian AtwoodVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsCybersecurityWomen Founded

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 63 more

    Verified email available

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Mahendra ShahVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Nathan DauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Alexander MaywegVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Verified email available

  • Clarissa BermanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Verified email available

  • Fei ChenVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Judith LiVerified

    Venture Capital · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Kent BerkleyVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Verified email available

  • Patrick HeronVerified

    Private Equity Firm · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Verified email available

  • Qi ZhuVerified

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Ron HuntVerified

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Verified email available

  • Steve B.Verified

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Verified email available

  • Yi ShiVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Carl Gordon

    Venture Capital

    SeedSeries AHealth and Hospital ServicesMedicalPharmaceuticals

    Portfolio: Good Start Genetics, Turning Point Therapeutics, Igenica, Odyssey Therapeutics and 18 more

    Contact details available

  • Carlo Rizzuto

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 60 more

    Contact details available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Charles Warden

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 61 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Daniel Estes

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 71 more

    Contact details available

  • Frank Kung

    Venture Capital, Founder, Private Equity Firm · United States

    Series BHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more

    Contact details available

  • Gordon Empey

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Ross Jaffe

    Venture Capital, Investor · United States

    Series BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 59 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Alan Frazier

    Private Equity Firm · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Andrew Goldberg

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Anna H. Chen

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Beckie Robertson

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Ben Magnano

    Private Equity Firm · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Bill Link

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Brian Morfitt

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Craig Slutzkin

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Don Milder

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

See all 54 Passage Bio investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many Passage Bio investors are on Angel Roster?

Angel Roster lists 54 Passage Bio investors. 18 of them (33%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (46), Private Equity Firms (40) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Passage Bio investors invest in?

Among those that list a stage, the most common are Seed (12), Series A (6) and Series B (4).

Where are Passage Bio investors based?

Most are based in the United States (41), China (7) and Israel (2).

Which companies have Passage Bio investors backed?

The most-backed portfolio companies among them are Arcutis Biotherapeutics (32), Gritstone Oncology (28), MBX Biosciences (25), Aspen Neuroscience (24) and Rongchang Pharmaceutical (23).

How do I contact Passage Bio investors?

Create a free Angel Roster account to search and filter all 54, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.